nialamide has been researched along with Movement Disorders in 3 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Pinder, RM | 1 |
| Ungerstedt, U | 1 |
| Pfeifer, AK | 1 |
| Galambos, E | 1 |
3 other studies available for nialamide and Movement Disorders
| Article | Year |
|---|---|
Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig.
Topics: Animals; Corpus Striatum; Dopamine; Guinea Pigs; Injections; Isoquinolines; Male; Movement Disorders | 1975 |
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
Topics: Amphetamine; Animals; Apomorphine; Brain; Butyrophenones; Dopamine; Electrocoagulation; Haloperidol; | 1971 |
Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
Topics: Animals; Brain; Crowding; Dopamine; Fever; Mice; Movement Disorders; Nialamide; Norepinephrine; Parg | 1967 |